SCHEMBL6474889

SCHEMBL6474889

NC(=O)c1ccccc1C(=O)N1CCCC1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.59
RECQL P46063 1/20 0.59
TP53BP1 Q12888 1/20 0.57
L3MBTL3 Q96JM7 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
HTT P42858 3/20 0.56
NPC1 O15118 1/20 0.56
HPGD P15428 2/20 0.54
USP2 O75604 1/20 0.53
ALDH1A1 P00352 1/20 0.53
GLA P06280 1/20 0.51
POLB P06746 2/20 0.50
KDM4E B2RXH2 1/20 0.50
GAA P10253 1/20 0.50
MAPT P10636 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1583125 0.98 SMN1; SMN2 (0.59) TSHRRECQLTP53BP1L3MBTL3L3MBTL1
SCHEMBL5166136 0.98 SMN1; SMN2 (0.59) TSHRRECQLTP53BP1L3MBTL3L3MBTL1
SCHEMBL20567427 0.92 ALDH1A1 (0.61) TSHRTP53BP1L3MBTL3L3MBTL1MEN1
SCHEMBL10720608 0.90 TSHR (0.69) TSHRRECQLTP53BP1L3MBTL3L3MBTL1
SCHEMBL3090159 0.85 ALDH1A1 (0.59) TSHRRECQLTP53BP1L3MBTL3L3MBTL1
SCHEMBL5349455 0.84 SMN1; SMN2 (0.67) TSHRMEN1KMT2ASMN1; SMN2HTT
SCHEMBL4827189 0.82 ALDH1A1 (0.69) TSHRRECQLTP53BP1L3MBTL3L3MBTL1
Hydrochloric Acid SCHEMBL17559454 0.82 SMN1; SMN2 (0.65) TSHRMEN1KMT2ASMN1; SMN2HTT
SCHEMBL18544176 0.82 HPGD (0.53) TSHRRECQLMEN1KMT2ASMN1; SMN2
SCHEMBL1578279 0.81 CA12 (0.59) TSHRRECQLTP53BP1L3MBTL3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2074089-B1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2013-09-18 EP claimed
US-8222248-B2 Organic compounds NOVARTIS AG (CH) 2012-07-17 US claimed
EP-1575925-A1 NOVEL CARBOXAMIDES, THE PRODUCTION AND USE THEREOF AS MEDICAMENTS Boehringer Ingelheim International GmbH (DE) 2005-09-21 EP claimed
WO-2004056784-A1 NOVEL CARBOXAMIDES, THE PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-07-08 WO claimed
EP-2074089-B1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2013-09-18 EP disclosed
US-8222248-B2 Organic compounds NOVARTIS AG (CH) 2012-07-17 US disclosed
EP-1575925-A1 NOVEL CARBOXAMIDES, THE PRODUCTION AND USE THEREOF AS MEDICAMENTS Boehringer Ingelheim International GmbH (DE) 2005-09-21 EP disclosed
EP-1453789-A2 N,N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES Elan Pharmaceuticals, Inc. (US) 2004-09-08 EP disclosed
WO-2004056784-A1 NOVEL CARBOXAMIDES, THE PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-07-08 WO disclosed
WO-2003040096-A2 N, N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES ELAN PHARMACEUTICALS, INC. (US) 2003-05-15 WO disclosed